New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Scientists have been studying Parkinson’s for many years, but they still don’t fully understand why it happens. Without ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

Researchers at the Lawson Health Research Institute, part of St. Joseph’s Health Care London, are studying Ambroxol, a cough ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...